| Mepha Pharma AG - Rivastigmin-Mepha Patch 4.6 mg/24 h, Transdermale Pflaster |
| 68795 | | 01 | | Rivastigmin-Mepha Patch 4.6 mg/24 h | | Transdermale Pflaster | | N06DA03 | | Rivastigmin | | 15.11.2022 | | |
|
| Composition |
| rivastigminum 6.4 mg, 2-ethylhexylis acrylatis et vinylis acetatis polymerisatum, polyisobutylenum, silica colloidalis anhydrica, paraffinum perliquidum, Trägermaterial: polyethylenum/aluminium polyesterum, polyesterum, ad praeparationem pro 4.3 cm², cum liberatione 4.6 mg/24h. |
| Packungsbestandteile |
| Transdermale Pflaster | | | | | Principe actif | Concentr. |
|---|
| Rivastigmine | 6.4 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Rivastigmine | 6.4 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| 2-ethylhexylis Acrylatis | | | | Ad Praeparationem | 4.3 cm | | | Cum Liberatione | 4.6mg / 24h | | | Paraffine Perliquide | | | | Polyesterum | | | | Polyethylenum/aluminium Polyesterum | | Trägermaterial | | Polyisobutylenum | | | | Silica Colloidalis Anhydrica | | | | Vinylis Acetatis Polymerisatum | | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 30 | 39.51 | 59.40 | B | LS | Oui |
|
